Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2 results about "Sugar absorption" patented technology

Sugar Absorption. Abstract Carbohydrates in the diet are digested in the small intestine to glucose, galactose, and fructose, and these sugars are then absorbed by enterocytes lining the upper third of the intestinal villi. Absorption occurs in two steps: first across the brush border membrane, and the second across the basolateral membrane.

A food formula for stabilizing blood sugar of diabetic patients

PendingCN122350315ABiotechnologyPhyllochinon
This invention discloses a food formula for stabilizing blood sugar in diabetic patients, belonging to the field of functional foods and fermentation engineering technology. The formula consists of the following ingredients in parts by weight: 15-25 parts of purple wheat bran (No. 2), 5-10 parts of soybean flour, 5-10 parts of black soybean flour, 5-10 parts of peanut flour, 10-15 parts of walnut kernel flour, 10-20 parts of purple jujube powder, 0.5-2 parts of Haematococcus pluvialis astaxanthin microcapsule powder, 0.3-1.5 parts of lutein ester microcapsule powder, 2-5 parts of *Lactobacillus plantarum* post-biotic powder, 3-8 parts of psyllium husk powder, 3-8 parts of resistant dextrin, 0.3-1 part of chromium-enriched yeast powder, 2-6 parts of pumpkin powder, 1-4 parts of shiitake mushroom powder, and 3-8 parts of purple onion powder. This invention's formula synergistically intervenes in blood sugar metabolism through multiple pathways, including protecting pancreatic β-cells, regulating intestinal flora, alleviating oxidative stress, and delaying sugar absorption. It is safe for long-term consumption without side effects, providing diabetic patients with a dietary option to help stabilize blood sugar.
Owner:衷成华

A surface engineered goji-derived exosome ophthalmic formulation for the treatment of ocular surface disease

PendingCN122351361AOcular surface diseasePharmaceutical drug
The application discloses a surface-engineered Gouqi-source exosome ophthalmic preparation for treating ocular surface diseases, and belongs to the technical field of ocular surface drug delivery and plant-source exosome preparation. The preparation takes Gouqi-source exosomes as the main body, takes a mucin-related peptide-anchor molecule complex capable of combining with, adsorbing, intertwining or anchoring the ocular mucosa, epithelial sugar absorption or mucin network, and having an ocular surface repair effect as a surface modification unit, and is used for improving the residence capacity of the exosomes on the ocular surface and enhancing the ocular surface repair effect.
Owner:ZHONGSHAN OPHTHALMIC CENT SUN YAT SEN UNIV